Skip to main content
logo
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.93
+0.57 (7.74%)
At close: Aug 7, 2026, 4:00 PM EDT
7.95
+0.02 (0.25%)
Pre-market: Aug 10, 2026, 7:45 AM EDT

Xeris Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,4461,305507325181366
Market Cap Growth
64.44%157.58%56.05%79.10%-50.46%24.75%
Enterprise Value
1,6131,452706.39481.35257.33351.51
Last Close Price
7.937.853.392.351.332.93

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-2447.71----
Forward PE
44.0664.50----
PS Ratio
4.314.472.491.981.647.38
PB Ratio
-95.32-17.10-47.864.013.84
P/FCF Ratio
25.9746.72----
P/OCF Ratio
25.5445.58----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.814.973.482.942.337.09
EV/EBITDA Ratio
33.0839.18----
EV/EBIT Ratio
44.0958.32----
EV/FCF Ratio
28.9851.98----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-22.5318.40-8.45-33.284.350.92
Debt / EBITDA Ratio
5.946.97----
Debt / FCF Ratio
5.209.24----
Net Debt / Equity Ratio
-17.2310.74-6.75-23.111.68-0.15
Net Debt / EBITDA Ratio
3.443.97-9.26-4.95-1.090.13
Net Debt / FCF Ratio
3.015.27-5.28-3.18-0.740.15
Asset Turnover
0.840.830.630.490.340.21
Inventory Turnover
0.600.730.850.901.061.01
Quick Ratio
0.951.481.121.172.081.52
Current Ratio
1.452.191.671.642.541.80
Return on Equity (ROE)
-868.01%-6.96%301.32%-324.20%-134.83%-190.28%
Return on Assets (ROA)
9.20%7.05%-10.01%-12.93%-24.88%-49.69%
Return on Invested Capital (ROIC)
19.15%12.99%-14.36%-24.75%-79.87%-339.40%
Return on Capital Employed (ROCE)
14.75%10.03%-14.95%-17.66%-33.03%-64.65%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.04%----
FCF Yield
3.85%2.14%----
Buyback Yield / Dilution
-10.29%-17.69%-6.61%-1.51%-71.62%-85.32%
Total Shareholder Return
-10.29%-17.69%-6.61%-1.51%-71.62%-85.32%
SEC Filings: 10-K · 10-Q